Literature DB >> 11443558

Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in northern Malawi.

G F Black1, H M Dockrell, A C Crampin, S Floyd, R E Weir, L Bliss, L Sichali, L Mwaungulu, H Kanyongoloka, B Ngwira, D K Warndorff, P E Fine.   

Abstract

Interferon (IFN)-gamma responsiveness to 12 purified protein derivative (PPD) and new tuberculin antigens from 9 species of mycobacteria was assessed, using a whole blood assay, in 616 young adults living in northern Malawi, where Mycobacterium bovis bacille Calmette-Guérin (BCG) vaccination provides no protection against pulmonary tuberculosis. The prevalence of IFN-gamma responsiveness was highest for PPDs of M. avium, M. intracellulare, and M. scrofulaceum (the MAIS complex). Correlations between responsiveness paralleled genetic relatedness of the mycobacterial species. A randomized, controlled trial was carried out, to assess the increase in IFN-gamma responsiveness to M. tuberculosis PPD that can be attributed to M. bovis BCG vaccination. The BCG-attributable increase in IFN-gamma response to M. tuberculosis PPD was greater for individuals with low initial responsiveness to MAIS antigens than for those with high initial responsiveness. Although not statistically significant, the trend is consistent with the hypothesis that prior exposure to environmental mycobacteria interferes with immune responses to BCG vaccination.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11443558     DOI: 10.1086/322042

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  44 in total

1.  A phase IIa trial of the new tuberculosis vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis-infected adults.

Authors:  Thomas J Scriba; Michele Tameris; Erica Smit; Linda van der Merwe; E Jane Hughes; Blessing Kadira; Katya Mauff; Sizulu Moyo; Nathaniel Brittain; Alison Lawrie; Humphrey Mulenga; Marwou de Kock; Lebohang Makhethe; Esme Janse van Rensburg; Sebastian Gelderbloem; Ashley Veldsman; Mark Hatherill; Hendrik Geldenhuys; Adrian V S Hill; Anthony Hawkridge; Gregory D Hussey; Willem A Hanekom; Helen McShane; Hassan Mahomed
Journal:  Am J Respir Crit Care Med       Date:  2012-01-26       Impact factor: 21.405

Review 2.  Tuberculosis vaccines in clinical trials.

Authors:  Rosalind Rowland; Helen McShane
Journal:  Expert Rev Vaccines       Date:  2011-05       Impact factor: 5.217

Review 3.  Orchestration of pulmonary T cell immunity during Mycobacterium tuberculosis infection: immunity interruptus.

Authors:  Samuel M Behar; Stephen M Carpenter; Matthew G Booty; Daniel L Barber; Pushpa Jayaraman
Journal:  Semin Immunol       Date:  2014-10-11       Impact factor: 11.130

4.  Immune responses to mycobacterial antigens in the Gambian population: implications for vaccines and immunodiagnostic test design.

Authors:  Johan Vekemans; Martin O C Ota; Jackson Sillah; Katherine Fielding; Mark R Alderson; Yasir A W Skeiky; Wilfried Dalemans; Keith P W J McAdam; Christian Lienhardt; Arnaud Marchant
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

5.  What has Karonga taught us? Tuberculosis studied over three decades.

Authors:  A C Crampin; J R Glynn; P E M Fine
Journal:  Int J Tuberc Lung Dis       Date:  2009-02       Impact factor: 2.373

6.  Mycobacterial purified protein derivatives stimulate innate immunity: Malawians show enhanced tumor necrosis factor alpha, interleukin-1beta (IL-1beta), and IL-10 responses compared to those of adolescents in the United Kingdom.

Authors:  Rosemary E Weir; Gillian F Black; Hazel M Dockrell; Sian Floyd; Paul E M Fine; Steven D Chaguluka; Sally Stenson; Elizabeth King; Bernadette Nazareth; David K Warndorff; Bagrey Ngwira; Amelia C Crampin; Lorren Mwaungulu; Lifted Sichali; Elizabeth Jarman; Linda Donovan; Jenefer M Blackwell
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

Review 7.  Whole blood assay and visceral leishmaniasis: Challenges and promises.

Authors:  Om Prakash Singh; Shyam Sundar
Journal:  Immunobiology       Date:  2014-01-31       Impact factor: 3.144

8.  Gamma interferon responses induced by a panel of recombinant and purified mycobacterial antigens in healthy, non-mycobacterium bovis BCG-vaccinated Malawian young adults.

Authors:  Gillian F Black; Rosemary E Weir; Steven D Chaguluka; David Warndorff; Amelia C Crampin; Lorren Mwaungulu; Lifted Sichali; Sian Floyd; Lyn Bliss; Elizabeth Jarman; Linda Donovan; Peter Andersen; Warwick Britton; Glyn Hewinson; Kris Huygen; Jens Paulsen; Mahavir Singh; Ross Prestidge; Paul E M Fine; Hazel M Dockrell
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

9.  High-sensitive and rapid detection of Mycobacterium tuberculosis infection by IFN-gamma release assay among HIV-infected individuals in BCG-vaccinated area.

Authors:  Weimin Jiang; Lingyun Shao; Ying Zhang; Shu Zhang; Chengyan Meng; Yunya Xu; Lingli Huang; Yun Wang; Ying Wang; Xinhua Weng; Wenhong Zhang
Journal:  BMC Immunol       Date:  2009-05-28       Impact factor: 3.615

10.  Comparison of mantoux and tine tuberculin skin tests in BCG-vaccinated children investigated for tuberculosis.

Authors:  Wenli Pan; Lyness Matizirofa; Lesley Workman; Tony Hawkridge; Willem Hanekom; Hassan Mahomed; Gregory Hussey; Mark Hatherill
Journal:  PLoS One       Date:  2009-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.